Home/Filings/4/0001567619-18-002683
4//SEC Filing

van Elsas Andrea 4

Accession 0001567619-18-002683

CIK 0001435049other

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 7:28 PM ET

Size

6.8 KB

Accession

0001567619-18-002683

Insider Transaction Report

Form 4
Period: 2018-09-12
van Elsas Andrea
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2018-09-13$6.50/sh9,754$63,394264,286 total
  • Award

    Common Stock

    2018-09-12+67,825274,040 total
Footnotes (3)
  • [F1]Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2018.
  • [F2]The shares were sold to cover the tax obligation that occurred upon the vesting of RSUs.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Documents

1 file

Issuer

ADURO BIOTECH, INC.

CIK 0001435049

Entity typeother

Related Parties

1
  • filerCIK 0001714425

Filing Metadata

Form type
4
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 7:28 PM ET
Size
6.8 KB